Literature DB >> 27547167

Chronic Rhinosinusitis and Irritable Bowel Syndrome: A Case Report.

Mikhail Kogan1, Carlos Cuellar Castillo1, Melissa S Barber1.   

Abstract

INTRODUCTION: Chronic rhinosinusitis (CRS) and irritable bowel syndrome (IBS) can be comorbidities that are difficult to treat. In this patient, an evidence-informed treatment pathway guided by laboratory biomarkers was used to address both conditions. CASE
PRESENTATION: A 69-y-old female patient presented with a 50-y history of sinusitis that was worse in the winter, postnasal drip, frequent sore throats, gastrointestinal complaints, headaches, and yeast infections. Two sinus surgeries (in years 2000 and 2002) and multiple courses of antibiotics had not resolved her sinus symptoms. In addition to CRS and IBS, this patient was noted to have intestinal overgrowth of Candida albicans, multiple food sensitivities, and leaky gut syndrome.
CONCLUSION: Antifungal medication and dietary changes in the course of 8 mo resulted in the resolution of her CRS and IBS.

Entities:  

Year:  2016        PMID: 27547167      PMCID: PMC4982648     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  19 in total

Review 1.  Judicious antibiotic use and intranasal corticosteroids in acute rhinosinusitis.

Authors:  Catherine Butkus Small; Claus Bachert; Valerie J Lund; Augustine Moscatello; Anjuli S Nayak; William E Berger
Journal:  Am J Med       Date:  2007-04       Impact factor: 4.965

Review 2.  An evidence-based position statement on the management of irritable bowel syndrome.

Authors:  Lawrence J Brandt; William D Chey; Amy E Foxx-Orenstein; Lawrence R Schiller; Philip S Schoenfeld; Brennan M Spiegel; Nicholas J Talley; Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

3.  Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency.

Authors:  John S Leeds; Andrew D Hopper; Reena Sidhu; Alison Simmonette; Narges Azadbakht; Nigel Hoggard; Stephen Morley; David S Sanders
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-14       Impact factor: 11.382

4.  Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.

Authors:  E A Williams; J Stimpson; D Wang; S Plummer; I Garaiova; M E Barker; B M Corfe
Journal:  Aliment Pharmacol Ther       Date:  2008-09-09       Impact factor: 8.171

5.  [The therapeutic effects of eliminating allergic foods according to food-specific IgG antibodies in irritable bowel syndrome].

Authors:  Chong-mei Yang; Yan-qing Li
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2007-08

6.  Nutritional supplements as adjunctive therapy for children with chronic/recurrent sinusitis: pilot research.

Authors:  Linda A Linday; Jay N Dolitsky; Richard D Shindledecker
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2004-06       Impact factor: 1.675

Review 7.  Cost of adult chronic rhinosinusitis: A systematic review.

Authors:  Kristine A Smith; Richard R Orlandi; Luke Rudmik
Journal:  Laryngoscope       Date:  2015-01-30       Impact factor: 3.325

8.  Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  I M Carroll; T Ringel-Kulka; J P Siddle; Y Ringel
Journal:  Neurogastroenterol Motil       Date:  2012-02-20       Impact factor: 3.598

9.  Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial.

Authors:  So Ra Yoon; Jong Hwa Lee; Jae Hyang Lee; Ga Yoon Na; Kyun-Hee Lee; Yoon-Bok Lee; Gu-Hun Jung; Oh Yoen Kim
Journal:  Nutr J       Date:  2015-11-03       Impact factor: 3.271

Review 10.  Complementary and integrative treatments: rhinosinusitis.

Authors:  Malcolm B Taw; Chau T Nguyen; Marilene B Wang
Journal:  Otolaryngol Clin North Am       Date:  2013-04-28       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.